|
TIMELESS expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.619300E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.18270000000143E-05 |
| Normal-vs-Stage2 |
2.97810000005061E-06 |
| Normal-vs-Stage3 |
3.375000E-03 |
| Normal-vs-Stage4 |
5.654600E-01 |
| Stage1-vs-Stage2 |
1.694430E-01 |
| Stage1-vs-Stage3 |
5.933600E-01 |
| Stage1-vs-Stage4 |
2.987600E-02 |
| Stage2-vs-Stage3 |
1.161200E-01 |
| Stage2-vs-Stage4 |
5.900800E-03 |
| Stage3-vs-Stage4 |
9.131900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.802400E-04 |
| Normal-vs-AfricanAmerican |
2.795900E-03 |
| Normal-vs-Asian |
8.483000E-01 |
| Caucasian-vs-AfricanAmerican |
5.289800E-01 |
| Caucasian-vs-Asian |
1.331420E-01 |
| AfricanAmerican-vs-Asian |
1.273010E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.962400E-04 |
| Normal-vs-Female |
1.856810E-03 |
| Male-vs-Female |
4.293800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.921600E-02 |
| Normal-vs-Age(41-60Yrs) |
9.143500E-03 |
| Normal-vs-Age(61-80Yrs) |
3.5667000000017E-05 |
| Normal-vs-Age(81-100Yrs) |
6.49360000000154E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.280400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.838400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.274200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.802400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.798200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.938590E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.505600E-01 |
| Normal-vs-Grade 2 |
3.74189999996499E-06 |
| Normal-vs-Grade 3 |
1.396050E-03 |
| Normal-vs-Grade 4 |
6.033600E-01 |
| Grade 1-vs-Grade 2 |
3.193600E-02 |
| Grade 1-vs-Grade 3 |
3.856800E-01 |
| Grade 1-vs-Grade 4 |
7.182400E-01 |
| Grade 2-vs-Grade 3 |
1.450210E-01 |
| Grade 2-vs-Grade 4 |
1.041970E-02 |
| Grade 3-vs-Grade 4 |
6.897600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.19150000035917E-07 |
| Normal-vs-ccB subtype |
3.753900E-02 |
| ccA subtype-vs-ccB subtype |
1.166740E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.299600E-03 |
| Normal-vs-N1 |
3.334000E-01 |
| N0-vs-N1 |
6.699800E-02 |
|
|
